Back

Posted by

The lack of guidance on getting off GLP-1s leaves patients at risk

Dr. David Kessler, former FDA Commissioner and public health leader, explores how these drugs override the brain’s reward-driven eating habits but have notable side effects. These include developing eating disorders, muscle loss, and intestinal obstruction.

More Posts

You've reached the end.

The lack of guidance on getting off GLP-1s leaves patients … | 1440